CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Metastatic prostate cancer is an incurable disease that typically spreads beyond the prostate. The standard of care is to ...
Phase 2, Phase 3
Sevilla, Spain and 29 other locations
and abiraterone in patients with metastatic castration-resistant prostate cancer (mCRPC) who have received no prior cytotoxic chemo ...
Phase 3
Sevilla, Spain and 131 other locations
enzalutamide or abiraterone/prednisone alone in asymptomatic or mildly symptomatic subjects with progressive, metastatic castration-resistant prostate...
Phase 1, Phase 2
Jerez De La Frontera, Cadiz, Spain and 23 other locations
patients with progressive metastatic castration-resistant prostate cancer (mCRPC).The following assessment of prostate cancer...
Phase 3
Sevilla, Spain and 57 other locations
The purpose of this study is to evaluate the efficacy and safety of apalutamide in adult men with high-risk non-metastatic castration-resistant prostate...
Phase 3
Sevilla N/a, Spain and 388 other locations
to radiographic progression-free survival (rPFS) per 1) Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 for soft tissue and/or Prostate...
Phase 3
Sevilla, Spain and 322 other locations
plus docetaxel in participants with metastatic castration resistant prostate cancer (mCRPC), all participants will receive the doce...
Phase 3
Sevilla, Spain and 249 other locations
prednisone/prednisolone compared with placebo plus abiraterone and prednisone/prednisolone in participants with metastatic castrate-resistant prostate...
Phase 3
Sevilla, Spain and 183 other locations
in participants with high-risk, localized or locally advanced prostate cancer receiving primary radiation therapy results in an imp...
Phase 3
Sevilla, Spain and 271 other locations
hormonal therapy (NHT) in men with metastatic castration-resistant prostate cancer (mCRPC) who have previously been treated with on ...
Phase 3
Sevilla, Spain and 272 other locations
Clinical trials
Research sites
Resources
Legal